Continuous Glucose Monitoring Device Market in North America is expected to register a CAGR of 11.6% during the forecast period (2020-2026) - KBV Research

14-May-2020 | Report Format: Electronic (PDF)

Growth, Trends and Report Highlights

According to a new report North America Continuous Glucose Monitoring Device Market, published by KBV research, the North America Continuous Glucose Monitoring Device Market would witness market growth of 11.6% CAGR during the forecast period (2020-2026).

The US market dominated the North America Transmitters Market by Country in 2019, and would continue to be a dominant market till 2026; growing at a CAGR of 11.5 % during the forecast period. The Canada market is poised to grow at a CAGR of 13.9% during (2020 - 2026). Additionally, The Mexico market would witness a CAGR of 13.8% during (2020 - 2026).

The Homecare Settings market dominated the Canada Continuous Glucose Monitoring Device Market by End-user in 2019, growing at a CAGR of 12.7 % during the forecast period. The Hospitals market is experiencing a CAGR of 13.4% during (2020 - 2026). The Other End Users market is expected to witness a CAGR of 14.2% during (2020 - 2026).

The Sensors market dominated the Mexico Continuous Glucose Monitoring Device Market by Component in 2019, growing at a CAGR of 12.6 % during the forecast period. The Transmitters market would exhibit a CAGR of 13.8% during (2020 - 2026). Additionally, The Receivers market is showcasing highest CAGR of 14.3% during (2020 - 2026).

Report Structural Insights: https://www.kbvresearch.com/north-america-continuous-glucose-monitoring-device-market/

The market research report has exhaustive quantitative insights providing a clear picture of the market potential in various segments across the mentioned countries. The key impacting factors of the market have been discussed in the report with the elaborated company profiles of Abbott Laboratories, Medtronic PLC, F. Hoffmann-La Roche Ltd., Novo Nordisk A/S, DexCom, Inc., Ypsomed AG, Senseonics Holdings, Inc., GlySens, Incorporated, A. Menarini Diagnostics Ltd. (The Menarini Group), Echo Therapeutics, Inc., Johnson and Johnson.

North America Continuous Glucose Monitoring Device Market Segmentation

By Component

  • Sensors
  • Transmitters and
  • Receivers

By End User

  • Hospitals
  • Homecare Settings and
  • Other End Users

By Country

  • US Continuous Glucose Monitoring Device Market
  • Canada Continuous Glucose Monitoring Device Market
  • Mexico Continuous Glucose Monitoring Device Market
  • Rest of North America Continuous Glucose Monitoring Device Market

Companies Profiled

  • Abbott Laboratories
  • Medtronic PLC
  • Hoffmann-La Roche Ltd.
  • Novo Nordisk A/S
  • DexCom, Inc.
  • Ypsomed AG
  • Senseonics Holdings, Inc.
  • GlySens, Incorporated
  • Menarini Diagnostics Ltd. (The Menarini Group)
  • Echo Therapeutics, Inc.
  • Johnson and Johnson

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Continuous Glucose Monitoring Device Market Related Reports:

Global Market

Europe Market

Asia Pacific Market

LAMEA Market

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

SPECIAL PRICING & DISCOUNTS


  • Buy Sections of This Report
  • Buy Country Level Reports
  • Request for Historical Data
  • Discounts Available for Start-Ups & Universities
HAVE A QUESTION?

HAVE A QUESTION?

Call: +1(646) 600-5072

Unique Offerings Unique Offerings


  • Exhaustive coverage
  • The highest number of Market tables and figures
  • Subscription-based model available
  • Guaranteed best price
  • Support with 10% customization free after sale